Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

544353

AMWILL

img img img img
No Data Available

Amwill Health Care Limited Share Price Update

As of the latest trading session, Amwill Health Care Limited share price is currently at ₹ 48.6, which is down by ₹ -0.40 from its previous closing. Today, the stock has fluctuated between ₹ 48.60 and ₹ 50.90. Over the past year, Amwill Health Care Limited has achieved a return of -47.45 %. In the last month alone, the return has been 20.24 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Amwill Health Care Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    97.20

  • P/E Ratio (TTM)

    9.14

  • Beta

    1.10

  • Book Value / share

    34.60

  • Return on equity

    24.85%

  • EPS (TTM)

    5.36

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    1.50

info icon alternate text

Amwill Health Care Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 8.16
Operating Expense 0.00
Net Profit 1.50
Net Profit Margin (%) 18.38
Earnings Per Share (EPS) 299.18
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 40.58
Operating Expense 29.39
Net Profit 10.73
Net Profit Margin (%) 26.44
Earnings Per Share (EPS) 6.63
EBITDA 12.36
Effective Tax Rate (%) 9.83
Particulars MAR 2024 (Values in Cr)
Revenue 43.95
Operating Expense 27.52
Net Profit 12.50
Net Profit Margin (%) 28.44
Earnings Per Share (EPS) 8.01
EBITDA 17.00
Effective Tax Rate (%) 25.41
Particulars MAR 2023 (Values in Cr)
Revenue 30.17
Operating Expense 26.11
Net Profit 3.11
Net Profit Margin (%) 10.30
Earnings Per Share (EPS) 2.00
EBITDA 4.41
Effective Tax Rate (%) 25.41
Particulars MAR 2022 (Values in Cr)
Revenue 27.61
Operating Expense 24.28
Net Profit 2.57
Net Profit Margin (%) 9.30
Earnings Per Share (EPS) 1.65
EBITDA 3.66
Effective Tax Rate (%) 22.82
Particulars MAR 2021 (Values in Cr)
Revenue 18.00
Operating Expense 19.03
Net Profit -1.00
Net Profit Margin (%) -5.55
Earnings Per Share (EPS) -0.64
EBITDA -1.02
Effective Tax Rate (%) 2.91
Particulars MAR 2025 (Values in Cr)
Book Value / Share 34.60
ROE % 24.85
ROCE % 27.38
Total Debt to Total Equity 0.00
EBITDA Margin 30.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3431.72
ROE % 114.89
ROCE % 149.98
Total Debt to Total Equity 0.00
EBITDA Margin 38.68
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1534.10
ROE % 102.13
ROCE % 125.23
Total Debt to Total Equity 0.03
EBITDA Margin 14.62
Particulars MAR 2022 (Values in Cr)
Book Value / Share 495.97
ROE % 1285.00
ROCE % 756.82
Total Debt to Total Equity 0.62
EBITDA Margin 13.26
Particulars MAR 2021 (Values in Cr)
Book Value / Share -361.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -5.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.07
Total Assets 71.47
Total Liabilities 71.47
Total Equity 69.21
Share Outstanding 20003600
Price to Book Ratio 2.00
Return on Assets (%) 15.01
Return on Capital (%) 15.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.27
Total Assets 18.98
Total Liabilities 18.98
Total Equity 17.15
Share Outstanding 50000
Price to Book Ratio 0.00
Return on Assets (%) 65.85
Return on Capital (%) 72.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.85
Total Assets 12.39
Total Liabilities 12.39
Total Equity 4.60
Share Outstanding 30000
Price to Book Ratio 0.00
Return on Assets (%) 25.12
Return on Capital (%) 67.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.40
Total Assets 6.58
Total Liabilities 6.58
Total Equity 1.48
Share Outstanding 30000
Price to Book Ratio 0.00
Return on Assets (%) 39.06
Return on Capital (%) 159.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 8.28
Total Liabilities 8.28
Total Equity -1.08
Share Outstanding 30000
Price to Book Ratio 0.00
Return on Assets (%) -12.03
Return on Capital (%) 103.45
Particulars MAR 2025 (Values in Cr)
Net Income 11.90
Cash from Operations 7.26
Cash from Investing -46.21
Cash from Financing 41.32
Net change in Cash 0.67
Free Cash Flow 7.98
Particulars MAR 2024 (Values in Cr)
Net Income 16.76
Cash from Operations 0.93
Cash from Investing -1.38
Cash from Financing -0.01
Net change in Cash -4.45
Free Cash Flow 1.82
Particulars MAR 2023 (Values in Cr)
Net Income 4.17
Cash from Operations 5.78
Cash from Investing -1.27
Cash from Financing -0.08
Net change in Cash 3.43
Free Cash Flow 6.10
Particulars MAR 2022 (Values in Cr)
Net Income 3.33
Cash from Operations 4.04
Cash from Investing -0.05
Cash from Financing 0.00
Net change in Cash 2.95
Free Cash Flow 4.15
Particulars MAR 2021 (Values in Cr)
Net Income -1.03
Cash from Operations 0.27
Cash from Investing -0.80
Cash from Financing 0.07
Net change in Cash -0.65
Free Cash Flow 1.07
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.63 14.03 1.48 219.40 25.97 / 57.50
BLISS GVS PHARMA LTD 160.55 15.50 1.49 1698.44 105.05 / 190.65
CIPLA LTD 1519.30 22.55 3.72 122724.68 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 346.05 9.09 2.60 1018.46 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2457.05 43.67 24.37 41623.91 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.63 23.28 3.99 219.40 25.97 / 57.50
AMRUTAJAN HEALTH LTD 659.55 33.63 5.57 1906.80 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 8431.70 91.18 26.38 21079.25 6501.60 / 10653.05
BLISS GVS PHARMA LTD 160.55 21.67 1.53 1698.44 105.05 / 190.65

Amwill Health Care Limited shareholding pattern

Holding

28.19%
70.64%
1.15%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Amwill Health Care Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
48.60 -0.81 redarrow
red-green-graph indicator
12 Bearish
4 Bullish
  • 5 Days 47.50
  • 26 Days 43.90
  • 10 Days 45.60
  • 50 Days 45.70
  • 12 Days 45.00
  • 100 Days 51.50
  • 20 Days 43.90
  • 200 Days 63.60
46.33 PIVOT

First Support

42.67

First Resistance

52.67

Second Support

36.33

Second Resistance

56.33

Third Support

32.67

Third Resistance

62.67

RSI

69.66

ADX

26.08

MACD

1.15

Williams % R

-7.17

Commodity Channel Index (CCI)

93.62

Date

2026-01-05

Week

9200.00

Same Day

7200.00

Month

11543.00

1 Year

1.10

3 Year

1.11

Over 1 Month

20.24%

down

Over 1 Year

-47.45%

down

Over 3 Months

-5.95%

down

Over 3 Years

0.00%

down

Over 6 Months

-26.93%

down

Over 5 Years

0.00%

down

Amwill Health Care Limited Corporate Actions

Amwill Health Care Limited Share Price

Amwill Health Care Limited was originally incorporated on August 21, 2017 under the name Amwill Health Care Private Limited', dated August 22, 2017 issued by the Deputy Registrar of Companies, Karnataka at Bangalore. Further, Company was converted into a Public Limited Company and a fresh Certificate of Incorporation dated January 25, 2024 was issued by the Registrar of Companies, Karnataka at Bangalore with the change in name to Amwill Health Care Limited'.

Amwill Health Care Ltd is a derma-cosmetic development company, associated with contract manufacturers, distributor and third party product development agencies, which has enabled in developing capabilities, in manufacturing, packaging and distribution. The core focus of Company is on development of problem solving dermatological, cosmeceutical and aesthetical products, and therefore to direct all efforts towards product formulation and development, the Company has outsourced key functions such as manufacturing, prototype development and distribution to third parties, for effective management and execution.

The product profile of Company is divided into two categories, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific dermatological problem. Majority of products marketed by them, were developed by Promoter, Anand Gandhi, in the capacity of a sole proprietor of M/s. Amwill Healthcare.

The Company registered the first transaction of sale of cosmetic products in the year 2020. It launched a new product under the name XL-HYDRA', a face moisturiser and launched a new formulation in hair-care therapy under the name- Fin-XL Pro Gel' in a gel based formulation in 2021.

The Company has created a structured storage and distribution chain through one of its promoter group entities, M/s. Amderma Healthcare LLP, which was established under the guidance of Tarun Gandhi. It has entered into a carrying and forwarding agreement dated May 15, 2024 effective from January 1, 2024, with Amderma, for appointing Amderma as a Carrying and Forwarding Agent.

The Company is planning the Initial Public Offer aggregating 62,00,000 Equity Shares consisting a Fresh Issue of 50,00,000 Equity Shares and an Offer for Sale of 12,00,000 Equity Shares.

Parent organization Indian Private
NSE symbol [-]
Founded 2017
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Amwill Health Care Ltd?

Answer Field

Amwill Health Care Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 48.60 as on Jan 06 2026 03:28 PM.

What is the Market Cap of Amwill Health Care Ltd Share?

Answer Field

The market cap of Amwill Health Care Ltd for NSE ₹ 0.00 & for BSE ₹ 97.20 as on Jan 06 2026 03:28 PM.

What is the 52 Week High and Low of Amwill Health Care Ltd?

Answer Field

The 52 Week High and Low of Amwill Health Care Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 104.90 and ₹ 34.00.

What is 1 year return for Amwill Health Care Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Amwill Health Care Ltd Share?

Answer Field

As on Jan 06 2026 03:28 PM the price-to-earnings (PE) ratio for Amwill Health Care Ltd share is 9.14.

What is the PB ratio of Amwill Health Care Ltd Share?

Answer Field

As on Jan 06 2026 03:28 PM, the price-to-book (PB) ratio for Amwill Health Care Ltd share is 34.60.

How to Buy Amwill Health Care Ltd Share?

Answer Field

You can trade in Amwill Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Amwill Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Amwill Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Amwill Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59